News & Press

  • ONKOS SURGICAL® is ecstatic to be partnered with the Musculoskeletal Tumor Society in 2017

    July was Sarcoma Awareness Month and we couldn’t think of a better time to honor the esteemed members of the Musculoskeletal Tumor Society (MSTS) and the work they do on a day to day basis. The members of the MSTS and the patients they treat

    Read More
  • Sarcoma Campaign Summary

    Sarcoma Awareness Month Social Media Campaign July 2017 ONKOS SURGICAL Social Media Posts (All Outlets): July 1 What Does Sarcoma Awareness Mean to You? July 4 Happy 4th of July from ONKOS SURGICAL. July 6 Every Signature Makes a Big Difference! July 7 What Does Sarcoma Awareness Mean To You?

    Read More
  • Onkos Surgical ® Secures $17.6M in Series B Funding Led by Canaan Partners

    Onkos Surgical, Inc., a specialty medtech company focused on surgical oncology, today announced that it closed a $17.6 million round in Series B funding. Canaan Partners led the funding round and existing investors 1315 Capital and 3D Systems also participated.

    Read More
  • Until 20 Viewing

    Until 20 Screening

    Thank you to everyone who supported the Onkos Surgical September 15th NJ screening of Until 20. It was a remarkable night as a packed theatre in Morristown was able witness the profound impact James Ragan had in the final years of his life. We were all reminded of the struggles…

    Read More
  • 3D Surgical Model

    Onkos Surgical Supports Difficult Tumor Case with 3D Printed Medical Model

    Onkos Surgical, a dedicated surgical oncology company founded to bring innovation, advocacy and passion to the surgical oncology marketplace, supported a difficult chondrosarcoma case with the use of a 3D printed medical model.

    Read More
  • Onkos Surgical Launches to Focus Exclusively on the Pediatric and Adult Surgical Oncology Market

    Onkos Surgical, an innovative surgical oncology startup founded by Patrick Treacy, Antony Koblish and 1315 Capital, has announced it has closed a Series A round of financing led by 1315 Capital to bring innovation, advocacy and passion to the surgical oncology marketplace.

    Read More